Abstract
Inherited cardiomyopathies can present with malignant arrhythmias prior to overt structural changes, so called “concealed cardiomyopathy”. However, current guidelines recommend only “arrhythmia-syndrome focused” genetic testing following unexplained sudden cardiac death (SCD).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
